The FDA has addressed a report to the US House Committee of Appropriations and the US Senate Committee of Appropriations concerning CBD. On today\u2019s show, Tony Frischknecht looks into this report and reflects back on some similar meetings that took place in 2008-2009 about medical cannabis, relating it to the current issue at hand. He highlights the concerns he has about the report, mainly the associated health risks of CBD that were pointed out. He also points out that included in the report is FDA\u2019s willingness to open their doors for discussions. Tread carefully when dealing with the federal government. Learn more about this report for further information.
Love the show? Subscribe, rate, review, and share!
Join the Plant Problems Community today:
\n